RxDoctor Payments Data

Jaspreet Singh, MD

Pain Medicine · Palmdale, CANPI 1407297146

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 79.5% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $21,325 and has fallen 97.5% since, to $538 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,866in general payments, 2019–2025

Across 234 payments — averaging $161.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$30K
  • Nevro Corp.$4K
  • Abbott$1K
  • Medtronic$924
  • Vertos Medical, Inc.$352
  • Foundation Fusion Solutions, LLC$290
  • plus $853 from 20 others
$1,538in research payments, 2019–2025

Across 2 payments — averaging $768.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$2K

What the payments were for

  • Consulting fees$3,80010%
  • Speaking & faculty fees$20,80055%
  • Travel & lodging$4,24611%
  • Food & beverage$9,02024%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,866 in reported general payments places this provider in the 90th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024
$287,015
Medicare patients
243
Services billed
2,126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin383$3,451
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen175$2,532
Pregabalin89$2,382
Lidocaine35$2,276
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen103$2,031
Celecoxib58$1,733
Baclofen264$1,403
Diclofenac Sodium126$1,338
Acetaminophen-CodeineAcetaminophen With Codeine44$781
Naloxone Hcl11$538
Methocarbamol113$485
Tramadol Hcl111$396
Cyclobenzaprine Hcl43$274
Tizanidine Hcl53$198
Meloxicam93$156

Paid to pharmacies, not to this prescriber.

Other pain medicine in Palmdale

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →